OMRON Healthcare Acquires Dutch Digital Health Co. Luscii Healthtech

The deal, valued at an undisclosed amount, marks a strategic move by OMRON to expand its digital health offerings and strengthen its position in the healthcare market.

In a significant development, OMRON Healthcare, a global leader in medical devices and health technology, has acquired Luscii Healthtech, a Dutch digital health company.

The deal, valued at an undisclosed amount, marks a strategic move by OMRON to expand its digital health offerings and strengthen its position in the healthcare market.

Since OMRON's seed investment in 2018, the two companies have collaborated closely, sharing knowledge and experience in the development of digital health.

Sharing thoughts, André van Gils, Sr general manager, Global Sales & Marketing HQ, OMRON Healthcare, said, “OMRON Healthcare is committed to developing life-saving cardiovascular health technologies in pursuit of our Going for Zero vision.’’

He further noted that Omron envisions expanding the business to digital health services and this acquisition aligns with that objective.

‘’We will continue to advance digital healthcare and work together to save lives,” Gils added.

Luscii is a digital health company that pioneered smart remote care and virtual wards. It provides a fully customizable platform and app for care at home, catering to over 150 diseases, including those affecting chronic hypertensive, cardiovascular, and respiratory patients.

As the market leader in the Netherlands, where Luscii collaborates with approximately 70% of the country’s hospitals, the platform also extends its presence to other markets, including the UK, Germany, and various other countries in Europe and Africa.

Moreover, Luscii's integrated care network approach seamlessly connects various healthcare stakeholders, including general practitioners (GPs), hospitals, community care, and virtual ward call centers.

"Benefiting from OMRON's global network, we can expand faster and realize our ambition even faster. Both my cofounders and all other team members are really looking forward to this next step in our mission," noted Prof Daan Dohmen, CEO and founder of Luscii.

He also acknowledged that the Dutch company’s Luscii's Vision of ‘creating space for care’ aligns with OMRON's objectives.

“It's been our dream for every patient to get the attention they deserve," Luscii CEO added.

Established in 1937 by Omron Corporation, OMRON focuses on creating innovative devices for health monitoring and therapy. Their solutions cater to both home-based users and clinical practitioners.

Further, Omron pioneered telehealth solutions, enabling remote patient monitoring. Operating in 110+ countries, OMRON has sold over 350 million blood pressure monitors worldwide.

Recent Acquisitions & Collaborations

The Danish pharmaceutical major, Novo Nordisk agreed to acquire Cardior for up to 1.025 billion euros, including an upfront payment and additional payments if certain development and commercial milestones are achieved.

This move seeks to strengthen Novo Nordisk’s pipeline of projects in cardiovascular disease.

Reportedly, the acquisition deal includes Cardior’s lead compound CDR132L, currently in phase II clinical development for the treatment of heart failure.

The American Cancer Society (ACS) and Color Health expanded their program to create a comprehensive cancer care solution, aimed at enhancing cancer care delivery for patients across the United States.

This comprehensive cancer solution is designed for employers and labor unions, providing support to their employees and member populations throughout all stages of the cancer journey.

Another case in point, Global tech giant Microsoft and chip maker NVIDIA have expanded their collaboration in the areas of generative AI, cloud computing, and accelerated computing to drive innovation in healthcare and life sciences.

This partnership seeks to merge Microsoft Azure's global scale, security, and advanced computing capabilities with NVIDIA DGX Cloud and the NVIDIA Clara suite of computing platforms, software, and services.